Amplitech Group Series B Right (AMPGZ) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMPGZ SEC filings page.
Amplitech Group, Inc. Series B Right (AMPGZ) reported $25.2M in revenue for fiscal year 2025, up 165.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue recovered sharply in FY2025, but weaker gross margins and heavier short-term obligations kept the business deeply cash-consuming.
FY2025 revenue grew165.0% , but gross profit grew only73.0% , meaning the rebound produced less gross profit per dollar. The gross-profit margin fell 12.7 percentage points to23.9% , confirming that volume recovery did not preserve prior economics.
The net loss was
Liabilities rose
Financial Health Signals
We do not publish a peer-relative financial health score for Amplitech Group, Inc. Series B Right, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Amplitech Group, Inc. Series B Right passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 operating efficiency signals passes.
Amplitech Group, Inc. Series B Right reported a net loss of $7.0M while operations used $8.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Amplitech Group, Inc. Series B Right generated $8.1M in revenue in Q2 2026. This represents a decrease of 26.8% from the same quarter a year earlier. Against the prior quarter it is up 50.9%.
Amplitech Group, Inc. Series B Right's EBITDA was -$2.7M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Amplitech Group, Inc. Series B Right reported a net loss of $3.1M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Amplitech Group, Inc. Series B Right earned -$0.12 per diluted share (EPS) in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Amplitech Group, Inc. Series B Right held $8.9M in cash as of Q2 2026; no long-term debt figure is on record for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Amplitech Group, Inc. Series B Right's gross margin was 27.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 20.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 20.1 percentage points.
Amplitech Group, Inc. Series B Right's operating margin was -39.6% in Q2 2026, reflecting core business profitability. This is down 22.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.3 percentage points.
Amplitech Group, Inc. Series B Right's net profit margin was -38.3% in Q2 2026, showing the share of revenue converted to profit. This is down 22.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.8 percentage points.
Amplitech Group, Inc. Series B Right's quarterly ROE was -6.6% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.5 percentage points.
Capital Allocation
Amplitech Group, Inc. Series B Right invested $1.4M in research and development in Q2 2026. This represents an increase of 108.6% from the same quarter a year earlier. Against the prior quarter it is up 173.2%.
Not reported for Q2 2026.
Not reported for Q2 2026.
AMPGZ Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.1M-26.8% | $5.3M+48.6% | $4.5M+141.6% | $6.1M+115.0% | $11.0M+336.2% | $3.6M+56.9% | $1.9M-53.8% | $2.8M-16.3% |
| Cost of Revenue | $5.8M-42.8% | $2.8M+15.4% | $3.5M+108.8% | $3.1M+110.8% | $10.2M+591.2% | $2.4M+70.9% | $1.7M-15.4% | $1.5M-21.9% |
| Gross Profit | $2.3M+161.2% | $2.6M+116.1% | $1.0M+416.4% | $3.0M+119.6% | $863K-18.4% | $1.2M+34.6% | $197K-90.4% | $1.3M-9.1% |
| R&D Expenses | $1.4M+108.6% | $503K-32.0% | $589K-74.2% | $699K+22.2% | $659K+43.2% | $740K+167.3% | $2.3M+162.3% | $572K+34.5% |
| SG&A Expenses | $4.1M+91.4% | $3.7M+57.5% | $3.7M+107.1% | $2.5M+33.1% | $2.1M-1.7% | $2.3M+15.0% | $1.8M+5.0% | $1.9M-6.1% |
| Operating Income | -$3.2Mn/m | -$1.6Mn/m | -$3.3Mn/m | -$221Kn/m | -$1.9Mn/m | -$1.9Mn/m | -$4.3Mn/m | -$1.1Mn/m |
| EBITDA | -$2.7Mn/m | -$1.1Mn/m | -$2.8Mn/m | $160Kn/m | -$1.7Mn/m | -$1.8Mn/m | -$4.2Mn/m | -$959Kn/m |
| Net Income | -$3.1Mn/m | -$1.5Mn/m | -$3.2Mn/m | -$188Kn/m | -$1.8Mn/m | -$1.8Mn/m | -$3.8Mn/m | -$1.2Mn/m |
| EPS (Basic) | -$0.12n/m | -$0.06n/m | -$0.14 | -$0.01 | -$0.08 | -$0.09 | -$0.28 | -$0.12n/m |
| EPS (Diluted) | -$0.12n/m | -$0.06n/m | -$0.14 | -$0.01 | -$0.08 | -$0.09 | -$0.28 | -$0.12n/m |
| Diluted Shares (Avg) | 25M+21.0% | 24M+19.5% | N/A | 21M | 21M | 20M | N/A | 10M+3.5% |
Not reported in any period shown, so not listed: Interest Expense, Income Tax.
AMPGZ Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $58.5M+20.3% | $59.7M+42.0% | $51.5M+19.1% | $47.2M+71.5% | $48.6M+91.4% | $42.1M+56.5% | $43.2M+37.6% | $27.5M-15.6% |
| Current Assets | $31.2M+24.9% | $33.2M+23.8% | $25.1M-11.5% | $21.6M+70.8% | $25.0M+114.8% | $26.8M+108.6% | $28.3M+65.2% | $12.6M-30.0% |
| Cash & Equivalents | $8.9M+78.5% | $11.8M-30.3% | $5.0M-74.2% | $8.4M+679.1% | $5.0M+391.1% | $16.9M+612.8% | $19.3M+187.2% | $1.1M-80.3% |
| Short-Term Investments | $4.1Mn/m | $6.6Mn/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $9.6M+21.6% | $9.9M+38.0% | $8.9M+17.4% | $8.9M+17.6% | $7.9M+4.3% | $7.1M-1.4% | $7.6M+16.1% | $7.5M+14.2% |
| Accounts Receivable | $6.3M+16.5% | $3.8M+72.0% | $3.3M+166.5% | $3.4M+166.5% | $5.4M+371.0% | $2.2M+69.8% | $1.3M-50.6% | $1.3M-30.6% |
| Long-Term Investments | $348K0.0% | $348K0.0% | $348K0.0% | $348K0.0% | $348K0.0% | $348K0.0% | $348K0.0% | $348Kn/m |
| Goodwill | $4.7M0.0% | $4.7M0.0% | $4.7M0.0% | $4.7M0.0% | $4.7M0.0% | $4.7M0.0% | $4.7M0.0% | $4.7M0.0% |
| Total Liabilities | $11.8M-8.4% | $11.4M+81.0% | $18.6M+224.9% | $11.4M+59.3% | $12.8M+171.4% | $6.3M+33.6% | $5.7M+21.2% | $7.2M+29.7% |
| Current Liabilities | $8.3M-6.2% | $7.8M+252.3% | $14.9M+870.5% | $7.6M+194.5% | $8.9M+435.7% | $2.2M+41.4% | $1.5M+2.4% | $2.6M+18.2% |
| Non-Current Liabilities | $3.4M-13.3% | $3.6M-12.1% | $3.7M-11.4% | $3.8M-16.5% | $4.0M+29.0% | $4.1M+29.7% | $4.2M+29.9% | $4.6M+37.3% |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $1.1M+877.8% |
| Total Equity | $46.8M+30.6% | $48.4M+35.2% | $32.9M-12.3% | $35.8M+75.8% | $35.8M+73.1% | $35.8M+61.4% | $37.5M+40.5% | $20.4M-24.8% |
| Retained Earnings | -$32.6Mn/m | -$29.5Mn/m | -$28.0Mn/m | -$24.8Mn/m | -$24.6Mn/m | -$22.9Mn/m | -$21.0Mn/m | -$17.2Mn/m |
AMPGZ Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$5.5Mn/m | -$3.1Mn/m | -$3.4Mn/m | -$999Kn/m | -$2.3Mn/m | -$2.0Mn/m | -$1.2Mn/m | -$1.7Mn/m |
| Depreciation & Amortization | $541K+111.4% | $532K+336.2% | $533K+255.1% | $381K+192.8% | $256K+98.1% | $122K-5.5% | $150K-12.6% | $130K+0.7% |
| Stock-Based Compensation | N/A | $633K+405.7% | N/A | N/A | N/A | $125K-9.8% | N/A | N/A |
| Capital Expenditures | N/A | N/A | $86K+419.0% | $443K+3371.4% | $126K+944.6% | $361K+22823.5% | $16K-60.4% | $13K-91.8% |
| Free Cash Flow | N/A | N/A | -$3.5Mn/m | -$1.4Mn/m | -$2.4Mn/m | -$2.4Mn/m | -$1.2Mn/m | -$1.7Mn/m |
| Investing Cash Flow | $2.0Mn/m | -$6.6Mn/m | -$86Kn/m | -$1.7Mn/m | -$3.6Mn/m | -$361Kn/m | -$16K-100.5% | -$13Kn/m |
| Financing Cash Flow | $686Kn/m | $9.8Mn/m | $6.8M-64.9% | $11K-99.4% | -$7Kn/m | -$4Kn/m | $19.4Mn/m | $1.8Mn/m |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
AMPGZ Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.9%+20.1pp | 48.0%+15.0pp | 22.8%+12.1pp | 48.6%+1.0pp | 7.8%-34.0pp | 33.0%-5.5pp | 10.7%-40.6pp | 47.5%+3.8pp |
| Operating Margin | -39.6%-22.1pp | -30.3%+22.2pp | -73.3% | -3.6%+34.8pp | -17.5%+44.6pp | -52.5%+9.8pp | -234.5% | -38.4%-11.0pp |
| Net Margin | -38.3%-22.2pp | -28.4%+22.7pp | -71.6% | -3.1%+38.9pp | -16.1%+46.3pp | -51.1% | -206.2% | -42.0%-15.8pp |
| Return on Equity | -6.6%-1.7pp | -3.1%+2.0pp | -9.8%+0.4pp | -0.5%+5.3pp | -5.0%+2.7pp | -5.1%+15.9pp | -10.2%-8.2pp | -5.8%-2.6pp |
| Return on Assets | -5.3%-1.6pp | -2.5%+1.8pp | -6.2%+2.6pp | -0.4%+3.9pp | -3.6%+2.6pp | -4.4%+13.0pp | -8.8%-7.2pp | -4.3%-1.6pp |
| Current Ratio | 3.76+0.9x | 4.25-7.9x | 1.68-16.8x | 2.85-2.1x | 2.82-4.2x | 12.10+3.9x | 18.45+7.0x | 4.91-3.4x |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.06+0.1x |
| Liabilities-to-Equity | 0.25-0.1x | 0.24+0.1x | 0.57+0.4x | 0.320.0x | 0.36+0.1x | 0.180.0x | 0.150.0x | 0.35+0.1x |
| Asset Turnover | 0.14-0.1x | 0.090.0x | 0.090.0x | 0.130.0x | 0.23+0.1x | 0.090.0x | 0.04-0.1x | 0.100.0x |
| FCF Margin | N/A | N/A | -78.4%-14.5pp | -23.7%+37.9pp | -21.6%+31.1pp | -65.8%-18.8pp | -63.9%-20.3pp | -61.6%-42.0pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Where Amplitech Group, Inc. Series B Right Ranks
Frequently Asked Questions
Amplitech Group, Inc. Series B Right (AMPGZ) reported $25.2M in total revenue for fiscal year 2025. This represents a 165.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Amplitech Group, Inc. Series B Right (AMPGZ) revenue grew by 165.0% year-over-year, from $9.5M to $25.2M in fiscal year 2025.
No, Amplitech Group, Inc. Series B Right (AMPGZ) reported a net loss of $7.0M in fiscal year 2025, with a net profit margin of -27.8%.
Amplitech Group, Inc. Series B Right (AMPGZ) had EBITDA of -$6.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
Amplitech Group, Inc. Series B Right (AMPGZ) had a gross margin of 23.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Amplitech Group, Inc. Series B Right (AMPGZ) had an operating margin of -29.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Amplitech Group, Inc. Series B Right (AMPGZ) had a net profit margin of -27.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Amplitech Group, Inc. Series B Right (AMPGZ) has a return on equity of -21.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Amplitech Group, Inc. Series B Right (AMPGZ) recorded an outflow of $9.7M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Amplitech Group, Inc. Series B Right (AMPGZ) recorded an outflow of $8.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Amplitech Group, Inc. Series B Right (AMPGZ) had $51.5M in total assets as of fiscal year 2025, including both current and long-term assets.
Amplitech Group, Inc. Series B Right (AMPGZ) invested $1.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Amplitech Group, Inc. Series B Right (AMPGZ) invested $2.7M in research and development during fiscal year 2025.
Amplitech Group, Inc. Series B Right (AMPGZ) had a current ratio of 1.68 as of fiscal year 2025, which is generally considered healthy.
Amplitech Group, Inc. Series B Right (AMPGZ) had a liabilities-to-equity ratio of 0.57 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
Amplitech Group, Inc. Series B Right (AMPGZ) had a return on assets of -13.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
At the end of fiscal year 2025, Amplitech Group, Inc. Series B Right (AMPGZ) held $5.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $8.7M over that year. Dividing the one by the other, the reported balance equals about 7 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Amplitech Group, Inc. Series B Right (AMPGZ) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Amplitech Group, Inc. Series B Right (AMPGZ) reported a net loss of $7.0M while operations used $8.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.